IN2014MN01871A - - Google Patents

Info

Publication number
IN2014MN01871A
IN2014MN01871A IN1871MUN2014A IN2014MN01871A IN 2014MN01871 A IN2014MN01871 A IN 2014MN01871A IN 1871MUN2014 A IN1871MUN2014 A IN 1871MUN2014A IN 2014MN01871 A IN2014MN01871 A IN 2014MN01871A
Authority
IN
India
Prior art keywords
riboflavin
hydrates
group
relates
present
Prior art date
Application number
Inventor
Ciro Caruso
Salvatore Troisi
Original Assignee
Iros R C S R L
Del Prete Antonio
Sanseverino Renato
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Iros R C S R L, Del Prete Antonio, Sanseverino Renato filed Critical Iros R C S R L
Publication of IN2014MN01871A publication Critical patent/IN2014MN01871A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/0013—Luminescence
    • A61K49/0017—Fluorescence in vivo
    • A61K49/0019—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules
    • A61K49/0021—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules the fluorescent group being a small organic molecule
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/525—Isoalloxazines, e.g. riboflavins, vitamin B2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B3/00—Apparatus for testing the eyes; Instruments for examining the eyes
    • A61B3/10—Objective types, i.e. instruments for examining the eyes independent of the patients' perceptions or reactions
    • A61B3/16—Objective types, i.e. instruments for examining the eyes independent of the patients' perceptions or reactions for measuring intraocular pressure, e.g. tonometers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/006—Biological staining of tissues in vivo, e.g. methylene blue or toluidine blue O administered in the buccal area to detect epithelial cancer cells, dyes used for delineating tissues during surgery
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Epidemiology (AREA)
  • Physics & Mathematics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Medical Informatics (AREA)
  • Ophthalmology & Optometry (AREA)
  • Surgery (AREA)
  • Biodiversity & Conservation Biology (AREA)
  • Oncology (AREA)
  • Optics & Photonics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Eye Examination Apparatus (AREA)
  • Medicinal Preparation (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

The present invention relates to a substance selected in the group consisting of riboflavin its esters salts and hydrates thereof for use in an ophthalmic diagnostic method.
IN1871MUN2014 2012-03-07 2013-03-01 IN2014MN01871A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT000355A ITMI20120355A1 (en) 2012-03-07 2012-03-07 COLORING SUBSTANCE FOR OPHTHALMOLOGICAL DIAGNOSTIC USE
PCT/IB2013/051635 WO2013132396A1 (en) 2012-03-07 2013-03-01 Coloring substance for diagnostic ophtalmologic use

Publications (1)

Publication Number Publication Date
IN2014MN01871A true IN2014MN01871A (en) 2015-07-03

Family

ID=45999982

Family Applications (1)

Application Number Title Priority Date Filing Date
IN1871MUN2014 IN2014MN01871A (en) 2012-03-07 2013-03-01

Country Status (10)

Country Link
US (1) US9370587B2 (en)
EP (1) EP2822604B1 (en)
AU (1) AU2013229096B2 (en)
BR (1) BR112014022177A2 (en)
CA (1) CA2900792A1 (en)
IN (1) IN2014MN01871A (en)
IT (1) ITMI20120355A1 (en)
RU (1) RU2639915C2 (en)
WO (1) WO2013132396A1 (en)
ZA (1) ZA201407224B (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT202000017059A1 (en) * 2020-07-14 2022-01-14 Frastema Ophthalmics Easyopht Group Srl In Forma Abbreviata Fe Group Srl DISPOSABLE APPLANATION HEAD FOR APPLANATION TONOMETER
EP4489796A1 (en) * 2022-03-07 2025-01-15 Opus Life Sciences, Llc Fluorescein formulations and kits

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2603632A (en) * 1949-04-06 1952-07-15 American Cyanamid Co Method of preparation of phosphoric acid esters of riboflavin
US5540227A (en) * 1995-05-17 1996-07-30 Poole; Thomas A. Controlled application of select ophthalmic agents
DE602005013423D1 (en) * 2004-12-06 2009-04-30 Univ Kyushu Nat Univ Corp COLOR COMPOSITION FOR STAINING AN OPHTHALMIC MEMBRANE
US20090192437A1 (en) * 2007-09-24 2009-07-30 The Johns Hopkins University Wearable photoactivator for ocular therapeutic applications and uses thereof
US9192594B2 (en) * 2009-07-27 2015-11-24 Renato Sanseverino Ophthalmic solution for protecting internal structures of the eyeball against UV-A rays or for the treatment of keratoconus with a trans-epithelial cross-linking technique
DE102009056597A1 (en) * 2009-12-02 2011-06-09 Tobias Brockmann Use of flavin derivatives and their salts for preparing a medicament for the treatment of pathologies of the internal limiting membrane (ILM), and the flavin derivative is riboflavin or roseoflavin
EP2392355A1 (en) * 2010-06-03 2011-12-07 Medical Technology Transfer Holding B.V. Staining composition

Also Published As

Publication number Publication date
EP2822604A1 (en) 2015-01-14
AU2013229096B2 (en) 2017-03-23
US20140371569A1 (en) 2014-12-18
CA2900792A1 (en) 2013-09-12
WO2013132396A1 (en) 2013-09-12
ZA201407224B (en) 2016-05-25
US9370587B2 (en) 2016-06-21
BR112014022177A2 (en) 2017-11-14
ITMI20120355A1 (en) 2013-09-08
EP2822604B1 (en) 2018-09-05
RU2639915C2 (en) 2017-12-25
RU2014139766A (en) 2016-04-27
AU2013229096A1 (en) 2014-10-23

Similar Documents

Publication Publication Date Title
AP4017A (en) Substituted triazolopyridines and their use as ttk inhibitors
GB2503411B (en) Sorting apparatus for arthropods and method of use thereof
EP3063262A4 (en) Devices and methods for three-dimensional tissue culturing
SG11201500606UA (en) Patient interface and method for making same
PT2874660T (en) Ophthalmic formulation and method for ameliorating presbyopia
SG11201504022RA (en) Glutamase inhibitors and method of use
IL236678A0 (en) Inhibitors of alpha-crystallin aggregation for the treatment for cataract
EP3038646A4 (en) Diagnostic methods and compositions for treatment of glioblastoma
IN2015DN01902A (en)
EP3003290A4 (en) Compositions and methods for induced tissue regeneration in mammalian species
EP3038663A4 (en) Method of performing sterilization cycle
EP3068758A4 (en) Ebna1 inhibitors and their method of use
EP2895068A4 (en) System and method for measuring cardiac output
PL2541503T3 (en) Rf-link margin measurement method and system
SG11201510021TA (en) Compositions and methods for use in medical diagnosis
EP2820615A4 (en) System and method for generation of medical report
SG11201500503TA (en) Apparatus for measuring the topography and thickness of the cornea and measuring method used
GB2517113B (en) Method involving pre-treating medical instruments
IL239117A0 (en) Method for the diagnosis of metachromatic leukodystrophy
PT2909828T (en) Slidable information system and method for the manufacture of and use of the information device of the system
IN2014MN01871A (en)
AP3759A (en) Method for preparing phenyloxymethyl-nitro-imidazole derivatives and use of the same
AU2012901130A0 (en) A composition and method for enhancing the permeability of a tissue of a subject to an active agent
PT2749556T (en) An improved process for the preparation of pure cyamemazine and salts thereof
IL228225A0 (en) Diaper and method for indication thereby